Home › Funds › Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. › NKTR

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. position in NKTR

NEKTAR THERAPEUTICS · Health Care

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. reported holding 121,326 shares of NKTR (NEKTAR THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$7.3M, representing 0.35% of its reported portfolio and ranking #27 among its reported holdings. Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. has disclosed NKTR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)121.33K sh
Reported value held$7.35M
Portfolio Weight0.35%
First reportedQ3 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s NKTR position evolved

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. first disclosed a stake in NKTR in Q3 2025 at 153,846 shares (US$8.8M). The position peaked in Q1 2026 at 122,326 shares, worth US$8.8M. Across 5 filings, Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 121,326 shares valued at US$7.3M — a reduction of -1,441 shares quarter over quarter.. Notable position changes include a 35% trim in Q1 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 153.85K $8.75M New
Q4 2025 188.11K $7.95M Add
Q1 2026 122.33K $8.80M Reduce
Q2 2026 122.77K $8.57M Hold
Q3 2026 121.33K $7.35M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS) is a Health Care company. 57 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. held NKTR?

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. has disclosed NKTR holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s current position in NKTR?

As of Q3 2026, Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 121.33K shares of NKTR (NEKTAR THERAPEUTICS), valued at $7.35M, representing 0.35% of its reported portfolio and ranking #27.

Has Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. been buying or selling NKTR?

In the latest 13F filing (Q3 2026), Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. reduced its position in NKTR. The position peaked in Q1 2026 at 122.33K shares.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.